Expression of protease-activated receptor 1 in oral squamous cell carcinoma

被引:38
|
作者
Liu, YN
Gilcrease, MZ
Henderson, Y
Yuan, XH
Clayman, GL
Chen, Z
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA
关键词
protease-activated receptor; thrombin; squamous cell carcinoma; matrix metalloproteinase; metastasis;
D O I
10.1016/S0304-3835(01)00504-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Protease-activated receptor 1 (PAR-1) is a G-coupled membrane protein. In this study, we analyzed the expression of PAR-1 in oral squamous cell carcinomas (SCCs). PAR-1 was expressed in oral SCCs, but the level of PAR-1 protein was lower in nonmetastatic cells than in metastatic cells. Thrombin stimulated the growth of metastatic cells, and both thrombin and thrombin receptor activation peptide (TRP) enhanced the adhesion of these cells to fibronectin, but had no effect on non-metastatic cells. Thrombin and TRP also induced matrix metalloproteinase (MMP)-2 and MMP-9 activities in metastatic cells. These results suggest that PAR-1 may contribute to the growth and invasive potential of oral SCC. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:173 / 180
页数:8
相关论文
共 50 条
  • [31] Protease-Activated Receptor-1 Expression in Rat Microglia after Trimethyltin Treatment
    Pompili, Elena
    Fabrizi, Cinzia
    Nori, Stefania Lucia
    Panetta, Barbara
    Geloso, Maria Concetta
    Corvino, Valentina
    Michetti, Fabrizio
    Fumagalli, Lorenzo
    JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2011, 59 (03) : 302 - 311
  • [32] Expression and cytoprotective effect of protease-activated receptor-1 in gastric epithelial cells
    Toyoda, N
    Gabazza, EC
    Inoue, H
    Araki, K
    Nakashima, S
    Oka, S
    Taguchi, Y
    Nakamura, M
    Suzuki, Y
    Taguchi, O
    Imoto, I
    Suzuki, K
    Adachi, Y
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2003, 38 (03) : 253 - 259
  • [33] Protease-activated receptor-1 in human brain: localization and functional expression in astrocytes
    Junge, CE
    Lee, CJ
    Hubbard, KB
    Zhang, ZB
    Olson, JJ
    Hepler, JR
    Brat, DJ
    Traynelis, SF
    EXPERIMENTAL NEUROLOGY, 2004, 188 (01) : 94 - 103
  • [34] Protease-activated receptor 2, rather than protease-activated receptor 1, contributes to the aggressive properties of synovial fibroblasts in rheumatoid arthritis
    Xue, Meilang
    Chan, Yee-Ka Agnes
    Shen, Kaitlin
    Dervish, Suat
    March, Lyn
    Sambrook, Philip N.
    Jackson, Christopher J.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (01): : 88 - 98
  • [35] Protease-activated receptor 4 is more important than protease-activated receptor 1 for the thrombin-induced procoagulant effect on platelets
    Lindahl, T. L.
    Macwan, A. S.
    Ramstrom, S.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 (08) : 1639 - 1641
  • [36] The expression of Protease-Activated Receptor (PAR) 2 reduces the IFNbeta expression in the heart
    Weithaeuser, A.
    Bobbert, P.
    Rauch, B.
    Zeichhardt, H.
    Schultheiss, H. P.
    Rauch, U.
    EUROPEAN HEART JOURNAL, 2013, 34 : 603 - 603
  • [37] Protease-activated receptor dimerization and signaling
    McLaughlin, JN
    Patterson, M
    Minshall, RM
    Malik, AB
    FASEB JOURNAL, 2006, 20 (04): : A251 - A252
  • [38] Protease-activated receptor 2 signaling upregulates angiogenic growth factors in renal cell carcinoma
    Zhang, Xiaotun
    Wang, Wenbin
    Mize, Gregory J.
    Takayama, Thomas K.
    True, Lawrence D.
    Vessella, Robert L.
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2013, 94 (01) : 91 - 97
  • [39] Prognostic value of activated Akt expression in oral squamous cell carcinoma
    Lim, J
    Kim, JH
    Paeng, JY
    Kim, MJ
    Hong, SD
    Lee, JI
    Hong, SP
    JOURNAL OF CLINICAL PATHOLOGY, 2005, 58 (11) : 1199 - 1205
  • [40] The Role of Protease-Activated Receptor 2 in Hepatocellular Carcinoma after Hepatectomy
    Tsai, Ming-Chao
    Lin, Chih-Che
    Chen, Ding-Wei
    Liu, Yueh-Wei
    Wu, Yi-Ju
    Yen, Yi-Hao
    Huang, Pao-Yuan
    Yao, Chih-Chien
    Chuang, Ching-Hui
    Hsiao, Chang-Chun
    MEDICINA-LITHUANIA, 2021, 57 (06):